Day: November 6, 2019

Oncolytics Biotech(R) Announces Publication of Positive REO 024 Study Results for Pelareorep in Combination with Keytruda(R) in Patients with Advanced Pancreatic Adenocarcinoma

Partial response of 17.4 months - beating historical overall survival data T cell receptor sequencing revealed the creation of new...

error: Content is protected !!